• Download Final Program ¢º
• Thursday, June 21
• Friday, June 22

Date & Time	6/21(Thu) 11:00-11:30	Place	Crystal Ballroom (2F)
Key strategies to overcome anticancer drug resistance in non-small cell lung cancer Ho-Young Lee (Seoul National University College of Pharmacy)

Date & Time	6/21(Thu) 11:30-12:20	Place	Crystal Ballroom (2F)
Interrogating the architecture of cancer genomes Peter Campbell (Wellcome Trust Sanger Institute, UK)

Session Title	Foundation of precision oncology
Date & Time	6/21(Thu) 09:00-10:40	Place	Crystal Ballroom A (2F)
1) Deep learning for predicting cancer vulnerabilities in clinical samples Jung Kyoon Choi (Korea Advanced Institute of Science and Technology (KAIST))
2) Application of PDX technology combined with cancer genome information for precision oncology Jong-Il Kim (Seoul National University College of Medicine)
3) Multi-platform genomic and epigenomic landscape of liver cancer development and progression Hyun Goo Woo (Ajou University School of Medicine)
4) Precision oncology platform for oncologists Jeeyun Lee (Sungkyunkwan University School of Medicine)

Session Title	Progress in surgical treatment for malignant disease
Date & Time	6/21(Thu) 09:00-10:40	Place	Crystal Ballroom B (2F)
1) Pylorus preserving gastrectomy and KLASS-04 Hyuk-Joon Lee (Seoul National University College of Medicine)
2) Laparoscopic liver resection: Real advantage? Ki-Hun Kim (University of Ulsan College of Medicine)
3) Breast reconstruction: related to the better life? Jeong Eon Lee (Sungkyunkwan University School of Medicine)
4) Robotic rectal cancer surgery surpasses laparoscopic resection Gyu-Seog Choi (Kyungpook National University School of Medicine)

Session Title	Genomic and immuno-oncology era in radiation oncology
Date & Time	6/21(Thu) 13:20-15:00	Place	Sapphire Ballroom A (3F)
1) Maneuvering or mining the "BIGGER" data O Kyu Noh (Ajou University School of Medicine)
2) Genomic and immunogenomic approach for prediction of radiation response In Ah Kim (Seoul National University College of Medicine)
3) Immune-modulating radiotherapy or vice versa Si Yeol Song (University of Ulsan College of Medicine)
4) Precision medicine based on RadioGenome using artificial intelligence Wonil Jang (Korea Institute of Radiological & Medical Sciences)

Date & Time	6/21(Thu) 09:00-10:40	Place	Sapphire Ballroom C (3F)
1) Spliceosomal gene mutations in cancer Eunhee Kim (Ulsan National Institute of Science and Technology (UNIST)
2) Genomic alterations of circulating tumor DNA in breast cancer patients Jisun Kim (University of Ulsan College of Medicine)
3) Architecture of genomic rearrangements molding fusion oncogenes in lung adenocarcinomas Young Seok Ju (Korea Advanced Institute of Science and Technology (KAIST)
4) Genome-wide association study for thyroid cancer and thyroid diseases Yul Hwangbo (Natioanl Cancer Center)

Session Title	Emerging molecular segments in gastrointestinal cancer
Date & Time	6/21(Thu) 09:00-10:40	Place	Crystal Ballroom C (2F)
1) Overcoming tumor heterogeneity in GI cancer: the PANGEA trial Daniel Catenacci (University of Chicago, USA)
2) Emerging molecular target therapy in gastrointestinal cancers Keun-Wook Lee (Seoul National University Bundang Hospital)
3) A close look into the immune signature of gastric cancer Taroh Satoh (Osaka University Graduate School of Medicine, Japan)

Session Title	Clinical trials and molecular imaging biomarkers
Date & Time	6/21(Thu) 09:00-10:40	Place	Sapphire Ballroom B (3F)
1) Quantitative imaging of cancer to precisely phenotype patients and tumors, to predict and assess treatment response Richard Leo Wahl (Washington University School of Medicine in St. Louis, USA)
2) Role of imaging in lymphoma Joo Hyun O (The Catholic University of Korea College of Medicine)
3) Molecular imaging biomarkers in lung and esophageal cancers for clinical trials Joon Young Choi (Sungkyunkwan University School of Medicine)
4) Role of metabolic imaging in response assessment to standardized chemotherapy in advanced gastric cancer Seunggyun Ha (Seoul National University College of Medicine)

Session Title	Plasma genotyping for precision medicine
Date & Time	6/21(Thu) 13:20-15:00	Place	Crystal Ballroom A (2F)
1) Circulating tumor DNA as a liquid biopsy: Overview Jong-Won Kim (Sungkyunkwan University School of Medicine)
2) cfDNA EGFR mutation detection Kyung A Lee (Yonsei University College of Medicine)
3) Plasma genotyping for breast and other cancers Sun-Young Kong (National Cancer Center)
4) Plasma sequencing for chromosomal instability detection Eunhae Cho (Green Cross Genome)

Session Title	Change of surgical strategy by multidisciplinary treatment
Date & Time	6/21(Thu) 13:20-15:00	Place	Crystal Ballroom B (2F)
1) Upfront surgery vs. neoadjuvant chemotherapy for marginally resectable pancreatic cancer Kyu-pyo Kim (University of Ulsan College of Medicine)
2) Reality of rectum preservation for locally advanced rectal cancer after preoperative chemoradiotherapy Kil Yeon Lee (Kyung Hee University School of Medicine)
3) Conversion surgery after systemic chemotherapy for metastatic gastric carcinoma Oh Jeong (Chonnam National University Medical School)
4) Determination of lymph node dissection after neoadjuvant chemotherapy for breast cancer Eun Sook Lee (National Cancer Center)

Session Title	Key issues in biosimilars
Date & Time	6/21(Thu) 13:20-15:00	Place	Crystal Ballroom C (2F)
1) Approaches and interactions in biosimilar development HoUng Kim (Celltrion Healthcare, Co., Ltd.)
2) Regulatory reviewer's perspective of MFDS Jong Won Kim (NIFDS/MFDS)
3) Biosimilars: Ready to trust them? : from a clinician's perspective In Hae Park (National Cancer Center)
4) To be an interchangeable drug: Future direction of research Tae-Yong Kim (Seoul National University Hospital)

Session Title	Multifocal lung cancer: The same or different? Aggressive or conservative?
Date & Time	6/21(Thu), 13:20-15:00	Place	Pine Room (3F)
1) Multifocal lung cancers: second primary or intrapulmonary metastasis? Hyae Young Kim (National Cancer Center)
2) Multifocal lung cancer: The same or different? Aggressive or conservative? - Pathologist's view Hyojin Kim (Seoul National University Bundang Hospital)
3) Multifocal lung cancers: Thoracic surgeon's view Sehoon Choi (University of Ulsan College of Medicine)
4) Medical oncologist's view Min Hee Hong (Yonsei University College of Medicine)

Session Title	Recent progress in cancer epigenomics
Date & Time	6/21(Thu) 13:20-15:00	Place	Sapphire Ballroom B (3F)
1) Targeted bisulfite sequencing of DNA methylation markers for blood-based detection of colorectal cancers Gyeong Hoon Kang (Seoul National University College of Medicine )
2) Functional unit of regulatory elements in breast cancer Kyung Hyun Ryu (Sookmyung Women's University)
3) Function of TET methylcytosine oxidases in cancer Myunggon Ko (Ulsan National Institute of Science and Technology (UNIST)
4) Nuclear export of HP1¥ã is responsible for p53 degradation in cervical cancer So Hee Kwon (Yonsei University College of Pharmacy)

Session Title	Microenvironment and tumorigenesis 1
Date & Time	6/21(Thu) 13:20-15:00	Place	Sapphire Ballroom C (3F)
1) Enriched environment boosts NK cell anti-tumor immunity via peripheral sympathetic nerves Yu Gan (Shanghai Cancer Institute, China)
2) Elimination of a specific subpopulation of T cells overcomes castration-resistance in prostate cancer therapy Wei-Qiang Gao (Shanghai Cancer Institute, China)
3) The mechanism and pathological features of the oncogenic KRAS stabilization by APC loss in colorectal cancer Kang-Yell Choi (Yonsei University College of Life Science and Biotechnology)
4) Metabolic regulation of hypoxia responses Young Il Yeom (Korea Research Institute of Bioscience & Biotechnology (KRIBB)

Session Title	Personalized cancer immunotherapy
Date & Time	6/21(Thu) 15:20-17:00	Place	Crystal Ballroom A (2F)
1) Generation of memory type antigen-specific cytotoxic T cells using MHC/peptide complex Se-Ho Park (Korea University)
2) Microbiome and precision medicine Hansoo Park (Gwangju Institute of Science and Technology (GIST)
3) Chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma Shinichi Makita (National Cancer Center Hospital, Japan)
4) Computational prediction of somatic mutation driven neoantigens Sangwoo Kim (Yonsei University College of Medicine)

Session Title	Hospice and palliative care
Date & Time	6/21(Thu) 15:20-17:00	Place	Crystal Ballroom B (2F)
1) Hospice and palliative care policy in South Korea Yoon-Jung Chang (National Cancer Center)
2) Hospice and palliative care services in Korea: focused on terminal cancer patients Jung Hye Kwon (Kangdong Sacred Heart Hospital)
3) Practice case of hospice and palliative care for terminal cancer patients (inpatient, home care, shared care) Su-jin Koh (Ulsan University Hospital)
Q & A

Session Title	Genomic alterations in premalignant lesions
Date & Time	6/21(Thu) 15:20-17:00	Place	Crystal Ballroom C (2F)
1) Genomic alterations in gastric cancer precursor lesions Kyoung-Mee Kim (Sungkyunkwan University School of Medicine)
2) Genomic alterations in dysplastic nodule and early hepatocellular carcinoma Young Nyun Park (Yonsei University College of Medicine)
3) Genomic alterations in preinvasive lesions of lung cancer Hyo Sup Shim (Yonsei University College of Medicine)
4) Molecular alterations in serrated precursor lesions of colorectal cancer Jung Ho Kim (Seoul National University Hospital)

Session Title	Bio-medical research using big accelerators
Date & Time	6/21(Thu) 15:20-17:00	Place	Sapphire Ballroom A (3F)
1) Potential use of synchrotron radiation for bio-medical studies Jae-Hong Lim (Pohang Accelerator Laboratory)
2) The status of KOMAC and its bio-medical applications Kye Ryung Kim (Korea Atomic Energy Research Institute (KAERI)
3) Status and opportunities for medical research with RAON Young Kwan Kwon (Institute for Basic Science (IBS)
4) Biomedical research using heavy ions Sei Sai (National Institutes for Quantum and Radiological Science and Technology, Japan)

Session Title	Optimization of adjuvant systemic treatment for EBC
Date & Time	6/21(Thu) 15:20-17:00	Place	Sapphire Ballroom B (3F)
1) Personalized approach in breast cancer to balance treatment outcome and patients quality of life Edith A. Perez (Mayo Clinic, USA)
2) Optimal duration and treatment for ER(+) breast cancer: Current evidence and future Jee Hyun Kim (Seoul National University Bundang Hospital)
3) Ramification of adjuvant anti-HER2 treatment: The more is the better? Keun Seok Lee (National Cancer Center)
4) Better strategies of adjuvant treatment for TNBC Joohyuk Sohn (Yonsei University College of Medicine)

Session Title	Microenvironment and tumorigenesis 2
Date & Time	6/21(Thu) 15:20-17:00	Place	Sapphire Ballroom C (3F)
1) Rac GTPase Activating Protein 1 promotes hepatocellular carcinoma growth by suppressing hippo pathway and ensuring cytokinesis in coordination with Yes-associated protein regulated nucleoporin TPR Zhi-Gang Zhang (Shanghai Cancer Institute, China)
2) Tumor microenvironment in ovarian cancer: a bioinformatics perspective Guanglei Zhuang (Shanghai Cancer Institute, China)
3) Systems pharmacology approaches for target & drug discovery towards cancer precision medicine Wankyu Kim (Ewha Womans University)
4) Large-scale pharmacogenomics based drug discovery for ITGB3 dependent chemoresistance in mesenchymal lung cancer Hyuk-Jin Cha (Seoul National University College of Pharmacy)

Session Title	Time-traveling in the IO space: Investigate the current status and foresight the IO space
Date & Time	6/21(Thu) 09:00-10:40	Place	Belle-vue Suite (36F)
1) Past: What happened? Overview of keynote trials Byoung Chul Cho (Yonsei University College of Medicine)
2) Present: What's going on? Moving from indistinct approaches to a patient specific approach using biomarker Andrey Loboda (MSD, USA)
3) Future: What's coming? Define future clinical combination strategy Michael Holmes (MSD, USA)

Session Title	Evaluating current and emerging strategies using checkpoint inhibitors: Where are we now and where are we going?
Date & Time	6/21(Thu) 13:20-15:00	Place	Belle-vue Suite (36F)
1) Bristol-Myers Squibb and the Checkmate development program in the brave new world of anticancer immunotherapy Kiyoshi Hashigami (Bristol-Myers Squibb K.K., Japan)
2) Combination is better than single? Ji-Youn Han (National Cancer Center)
3) Exploring opportunities to improve outcomes via "Patient Selection" Ross Soo (National University Cancer Institute, Singapore)

Session Title	Towards precision healthcare: Overcoming the challenges of NGS-based cancer profiling
Date & Time	6/21(Thu) 15:20-17:00	Place	Belle-vue Suite (36F)
1) Bioinformatics perspective: technical challenges in the NGS data analysis Sangwoo Kim (Yonsei University College of Medicine)
2) Pathologist perspective: better use of limited precious samples Yoon-La Choi (Sungkyunkwan University School of Medicine)
3) Oncologist experiences: clinical application of comprehensive genomic profiling Kyu-pyo Kim (University of Ulsan College of Medicine)

Session Title	The art of immunotherapy in NSCLC
Date & Time	6/21(Thu) 12:20-13:20	Place	Crystal Ballroom (2F)
Ji-Youn Han (National Cancer Center)

Session Title	Emerging horizons in gastric cancer immunotherapy
Date & Time	6/21(Thu) 12:20-13:20	Place	Sapphire Ballroom B (3F)
Min-Hee Ryu (University of Ulsan College of Medicine)

Session Title	Ceritinib: How to optimize treatment of ALK + NSCLC in 1L
Date & Time	6/21(Thu) 12:20-13:20	Place	Sapphire Ballroom C (3F)
Byoung Chul Cho (Yonsei University College of Medicine)

Session Title	Basic research 1
Date & Time	6/21(Thu) 17:00-18:00	Place	Crystal Ballroom A (2F)
1) Big data based clinical predictive modeling in immuno-oncology Su Bin Lim (National University of Singapore, Singapore)
2) Oncolytic vaccinia virus and anti-PD1-based combination therapy restores antitumor immunity in tumor microenvironment Badrinath Narayanasamy (Pusan National University)
3) Induction of chemokine receptor and suppression of inhibitory receptors of CD8 T cell effectively controlled HPV-associated tumor Sung-Jong Lee (St. Vincent's Hospital, The Catholic University of Korea)
4) Unleashing the therapeutic potential of CAR-T therapy using CRISPR/Cas9-mediated DGK knockout Inyoung Jung (ToolGen)

Session Title	Basic research 2
Date & Time	6/21(Thu) 17:00-18:00	Place	Crystal Ballroom B (2F)
1) Is inverse cancer comorbidity of patients with neurologic diseases real or illusion? A Korean nationwide population-based study Yoon Young Choi (Yonsei University Health System)
2) Prediction of pseudoprogression versus progression using machine learning algorithm in glioblastoma Bum-Sup Jang (Seoul National University Hospital)
3) Development and validation of machine learning mobile application "ImmunoGenius" for diagnosing tumors of unknown origin with immunohistochemistry profile using 1000 real case dataset Yosep Chong (The Catholic University of Korea College of Medicine)
4) Determining the optimal cervical carcinoma screening method in HIV positive and HIV negative Cambodian Women Sovannara Thay (Sihanouk Hospital Center of HOPE, Cambodia)

Session Title	Lung and H&N cancer
Date & Time	6/21(Thu) 17:00-18:00	Place	Crystal Ballroom C (2F)
1) Targeted sequencing analysisof pulmonary adenocarcinoma with multiple synchronous ground-glass/lepidic nodules Eunhyang Park (Seoul National University College of Medicine, Bundang Hospital)
2) Association of TP53 and CDH1 gene polymorphisms with lung, breast and colorectal cancer in the Bangladeshi population Mohammad Safiqul Islam (Noakhali Science and Technology University, Bangladesh)
3) Is stereotactic body radiotherapy for ultracentral lung tumor a feasible option? A systemic review and meta-analysis Chai Hong Rim (Korea University College of Medicine)
4) NOP14 promotes nasopharyngeal carcinoma progression by up-regulating mTORC2-AKT signaling Bo-Hua Kuang (Wuhuan Union Hospital, China)

Session Title	GI cancer 1 (HBP, Colorectal)
Date & Time	6/21(Thu) 17:00-18:00	Place	Pine Room (3F)
1) Clinical benefit of maintenance therapy for patients with advanced biliary tract cancer without progression on first line gemcitabine plus cisplatin Jae Won Hyung (Asan Medical Center)
2) Effect of sarcopenic obesity on postoperative pancreatic fistula after pancreaticoduodenectomy in patients with pancreas head cancer Youngju Ryu (Samsung Medical Center, Sungkyunkwan University School of Medicine)
3) Gold nanoparticles adhered and paclitaxel-loaded PLGA microspheres for synergistic chemo-photothermal treatment of pancreatic cancer Asmita Banstola (Keimyung University College of Pharmacy)
4) Two regimens of intraperitoneal chemotherapy after cytoreductive surgery improved survival of patients with colorectal peritoneal metastases Soo Yeun Park (Kyungpook National University School of Medicine)

Session Title	Radiation oncology
Date & Time	6/21(Thu) 17:00-18:00	Place	Sapphire Ballroom A (3F)
1) Validation of a novel molecular RPA categories in glioblastoma treated with radiotherapy and concurrent temozolomide: an Asian multi-institutional study Chan Woo Wee (Seoul National University Bundang Hospital)
2) The feasibility of spinal stereotactic ablative radiosurgery for spinal metastasis with epidural cord compression Yi-Jun Kim (Seoul National University Hospital)
3) Concurrent chemoradiotherapy for cervical cancer in a single institution: high-dose rate brachytherapy vs stereotactic body radiation therapy via helical tomotherapy Seongmin Kim (Korea University College of Medicine)

Session Title	Basic research (Colorectal cancer)
Date & Time	6/21(Thu) 17:00-18:00	Place	Sapphire Ballroom B (3F)
1) A targeted approach toward APC-mutated colorectal cancer Sang Bum Kim (Yonsei University College of Medicine)
2) Mutant KRAS-induced macrophage migration inhibitory factor (MIF) secretion promotes resistance to EGFR-blockade in colorectal cancer Jee Eun Jang (Seoul National Univeristy)
3) Identification of biomarker to predict response for preoperative chemoradiotherapy using comprehensive miRNA analysis in patient with rectal cancer Dongwon Baek (Kyungpook National University School of Medicine)
4) Mutational profiles of anal squamous cell carcinomas using whole-exome sequencing Sun Shin (The Catholic University of Korea)
5) STING-dependent signaling underlies IL-10 controlled inflammatory colitis Jeonghyun Ahn (University of Miami, USA)
6) SNAI1 and FBXL5 as potential novel biomarker for colorectal cancer Hee Dong Koh (Yonsei University College of Medicine)

Session Title	Supportive care, pediatric cancer and radiation oncology
Date & Time	6/21(Thu) 17:00-18:00	Place	Sapphire Ballroom C (3F)
1) A phase II study to assess the immunogenicity and safety of a 13-valent pneumococcal conjugated vaccination during adjuvant chemotherapy Woo Kyun Bae (Chonnam National University Hwasun Hospital)
2) Multicenter feasibility study of physician orders for life-sustaining treatment (POLST) for terminal cancer patients Ho Jung An (The Catholic University of Korea College of Medicine)
3) Analysis of the socioeconomic factors for renouncing further active therapy for the patients with brain metastasis of non-small cell lung cancer Young Zoon Kim (Samsung Changwon Hospital, Sungkyunkwan University School of Medicine)
4) Neurocognitive and psychological function in pediatric patients with brain tumor: pretreatment and follow-up evaluation Boram Ha (Proton Therapy Center, National Cancer Center)
5) Treatment outcomes of radiotherapy for primary spinal cord glioma Seo Hee Choi (Yonsei Cancer Center, Yonsei University College of Medicine)

Date & Time	6/21(Thu) 09:00-17:00	Place	Emerald Room (2F)

Date & Time	6/22(Fri) 10:20-10:50	Place	Crystal Ballroom (2F)
Translational research in surgical oncology Dong-Young Noh (Seoul National University College of Medicine)

Date & Time	6/22(Fri) 10:50-11:40	Place	Crystal Ballroom (2F)
New ways of targeting K-Ras Frank McCormick (UCSF Helen Diller Family Comprehensive Cancer Center, USA)

Date & Time	6/22(Fri) 12:50-13:20	Place	Sapphire Ballroom B (3F)
MicroDNA: Discovery of extrachromosomal circles of DNA and their roles in cancer Anindya Dutta (University of Virginia School of Medicine, USA)

Session Title	Promising anti-cancer drug pipeline in pre-clinical and clinical stages in Korea
Date & Time	6/22(Fri) 13:40-15:20	Place	Crystal Ballroom A (2F)
1) Introduction of National OncoVenture: a Korean national anti-cancer drug development program Young-Whan Park (National OncoVenture)
2) First-in-human phase 1 trial of HGF antibody (NOV1105, YYB101) in refractory solid tumor Jeeyun Lee (Sungkyunkwan University School of Medicine)
3) New vascular disrupting agent CKD-516 (NOV1204) development Kee-Won Kim (CKD Pharm.)
4) Preclinical development of an anti-cancer bispecific antibody targeting VEGF and DLL4, ABL001 (NOV1501) Jinhyung Ahn (ABL Bio Inc.)

Session Title	Tailored care for young women with cancer
Date & Time	6/22(Fri) 13:40-15:20	Place	Crystal Ballroom C (2F)
1) Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures Yeon Hee Park (Sungkyunkwan University School of Medicine)
2) Dilemmas associated with clinical application of genetic testing for young cancer patients Ji Soo Park (Yonsei Cancer Center)
3) Strategies for fertility preservation Jayeon Kim (CHA University School of Medicine)
4) Screening in dense breasts: challenges and options Woo Kyung Moon (Seoul National University College of Medicine )

Session Title	Recent updates and future perspectives on the hepato-biliary cancer
Date & Time	6/22(Fri) 13:40-15:20	Place	Sapphire Ballroom A (3F)
1) Recent advances in HCC systemic therapy - Where do we go from here? Ahmed Kaseb (MD Anderson Cancer Center, USA)
2) Now, we're getting Immune-therapy in Hepatocellular carcinoma Masafumi Ikeda (National Cancer Center Hospital East, Japan)
3) Recent treatment updates on the biliary tract cancer Do-Youn Oh (Seoul National University College of Medicine)

Session Title	Current debate in the oncologic management of rectal cancer
Date & Time	6/22(Fri) 13:40-15:20	Place	Sapphire Ballroom B (3F)
1) Total neoadjuvant therapy (TNT) for rectal cancer Hyung Jin Kim (The Catholic University of Korea College of Medicine)
2) Can radiation be omitted? Se-Jin Baek (Korea University College of Medicine)
3) Update MR imaging in rectal cancer Seung Hyun Cho (Kyungpook National University School of Medicine)
4) Prevention and prediction of local recurrence after curative rectal cancer surgery Soo Yeun Park (Kyungpook National University School of Medicine)

Session Title	Multi-omics approaches in cancer research
Date & Time	6/22(Fri) 13:40-15:20	Place	Sapphire Ballroom C (3F)
1) Chemical genomics approach for discovery of EMT-subtype selective intervention opportunities Hyun Seok Kim (Yonsei University College of Medicine)
2) nc886, a non-coding RNA induced by TGF-¥â, modulates global gene expression by inhibiting the miRNA pathway Yong Sun Lee (National Cancer Center)
3) Proteomic multi-marker panel improves diagnostic performance of early hepatocellular carcinoma Youngsoo Kim (Seoul National University College of Medicine)
4) A transfer-RNA-derived small RNA affects translation in rapidly dividing cells and a target for hepatocellular carcinoma Hak Kyun Kim (Stanford University, USA)

Session Title	From scientific lead to companion diagnostics (CDx) approval process in Korea
Date & Time	6/22(Fri) 15:40-17:20	Place	Crystal Ballroom A (2F)
1) Developing ddPCR EGFR mutation test as CDx: Sharing experience for CDx approval Jee-Eun Kim (GENCURIX Inc.)
2) Clinical NGS diagnostics: NGS assay selection, validation and approval Jihun Kim (University of Ulsan College of Medicine)
3) Experience in NGS-based in vitro diagnostic medical device development for cancer gene testing Kwang Joong Kim (NGeneBio)
4) Omics technology: Developing prediction assay for CDx platform in academia Kyoung-Mee Kim (Sungkyunkwan University School of Medicine)

Session Title	Multidisciplinary care of BRCA mutation carriers
Date & Time	6/22(Fri) 15:40-17:20	Place	Crystal Ballroom B (2F)
1) Genetic testing, counselling, and issues in clinical application Han-Byoel Lee (Seoul National University Hospital)
2) Breast cancer surveillance and risk-reducing mastectomy Sang-Ah Han (Kyung Hee University School of Medicine)
3) Ovarian cancer surveillance and risk-reducing surgery Myong Cheol Lim (National Cancer Center)
4) Systemic therapy in ovarian cancer with BRCA mutation Yong Wha Moon (CHA University School of Medicine)

Session Title	Update of gastric cancer research in Korea
Date & Time	6/22(Fri) 15:40-17:20	Place	Crystal Ballroom C (2F)
1) Feasibility of laparoscopic gastrectomy for advanced gastric cancer (result of COACT 1001 trial) Young-Woo Kim (National Cancer Center)
2) Olaparib for management of advanced gastric cancer Do-Youn Oh (Seoul National University College of Medicine)
3) Immunotherapy for advanced gastric cancer Yoon-Koo Kang (University of Ulsan College of Medicine)
4) Role of eradication of Helicobacter pylori after endoscopic resection of gastric cancer Il Ju Choi (National Cancer Center)

Session Title	Tumor immunity and immunotherapy
Date & Time	6/22(Fri) 15:40-17:20	Place	Sapphire Ballroom B (3F)
1) Status of immunotherapy for cancer patients in China Lihui Zou (Beijing Medical Association, China)
2) Regular T cells and their potential in clinical application Xundong Wei (Biotherapy Center, Beijing Hospital, China)
3) Comprehensive assessment of tumor microenvironment for precision immune-oncology Byoung Chul Cho (Yonsei University College of Medicine)
4) Overcoming immune cell exhaustion by a new APC based vaccine Chang-Yuil Kang (Seoul National University College of Pharmacy)

Session Title	A forum on tumor microenvironment
Date & Time	6/22(Fri) 13:40-15:20	Place	Belle-vue Suite (36F)
1) Targeting TME - Vasculature and Stroma Mariusz Lukanowski (Lilly, Denmark)
2) Research Effort in TME Mariusz Lukanowski (Lilly, Denmark)
3) Targeting TME Vasculature and GC Taroh Satoh (Osaka University Graduate School of Medicine, Japan)

Session Title	Harnessing the power of immunotherapy and targeted therapy in lung cancer
Date & Time	6/22(Fri) 11:50-12:50	Place	Crystal Ballroom (2F)
Harald A. Weber (Roche, Singapore)

Session Title	Current status and real world experience of anti-angiogenesis in Advanced Gastric Cancer
Date & Time	6/22(Fri) 11:50-12:50	Place	Sapphire Ballroom B (3F)
Taroh Satoh (Osaka University Graduate School of Medicine, Japan)

Session Title	Reassuring the absolute survival benefit of ALK sequential therapy and the value of First-in-class ROS1 inhibitor
Date & Time	6/22(Fri) 11:50-12:50	Place	Sapphire Ballroom C (3F)
Yasushi Goto (National Cancer Center Hospital, Japan)

Date & Time	6/22(Fri) 09:00-10:00	Place	Crystal Ballroom (2F)
1) Laparoscopy-assisted versus open D2 distal gastrectomy for advanced gastric cancer: Five year survival outcome from a randomized phase II multicenter clinical Young-Woo Kim (National Cancer Center)
2) YAP/TAZ initiates gastric tumorigenesis via upregulation of MYC Wonyoung Choi (KAIST)
3) Extrinsic phagocyte-dependent STING-signaling dictates the immunogenicity of dying cells Jeonghyun Ahn (University of Miami, USA)

Session Title	Basic research 3
Date & Time	6/22(Fri) 09:00-10:00	Place	Pine Room (3F)
1) Time sequential changes of epithelial-mesenchymal transition signaling induced by ionizing radiation using next-generation sequencing in glioblastoma Yi-Jun Kim (Seoul National University Hospital)
2) Cutting-edge research in basic and translational heavy-ion radiobiology: Focused on radioresistant cancer stem cells Sei Sai (National Institutes for Quantum and Radiological Science and Technology, Japan)
3) Exploring the interaction of tumor cells and tumor-associated macrophages in colorectal cancer progression Yeo Song Lee (Samsung Medical Center)

Session Title	Lung cancer
Date & Time	6/22(Fri) 09:00-10:00	Place	Sapphire Ballroom C (3F)
1) Cell-free DNA quantification reflects survival in non-small cell lung cancer patients with low metabolic tumor burden Yoon Ji Choi (Korea University College of Medicine)
2) Integrin ¥â3 inhibition enhances the antitumor activity of ALK inhibitor in ALK-rearranged non-small cell lung cancer Mi-Sook Lee (Sungkyunkwan University School of Medicine)
3) Impact of FDG PET/CT in selection of patients for adjuvant chemotherapy in stage IA non-small cell lung cancer Hye Lim Park (Seoul St. Mary's Hospital, the Catholic University of Korea College of Medicine)

Session Title	Gynecologic cancer
Date & Time	6/22(Fri) 13:40-14:10	Place	Crystal Ballroom B (2F)
1) Genomic profiling of the residual disease of advanced-stage ovarian cancer after neoadjuvant chemotherapy Yong Jae Lee (Yonsei University College of Medicine)
2) Long non-coding RNAs signatures to improve prognosis prediction of endometrial cancer Qinyang Xu (Shanghai Jiao Tong University, China)

Session Title	GI cancer 2 (Esophagus, stomach, CRC)
Date & Time	6/22(Fri) 13:40-15:20	Place	Pine Room (3F)
1) Early prediction of response to radiotherapy using inter-fractional 18F-FDG PET/CT in esophageal cancer Nalee Kim (Yonsei University College of Medicine)
2) Low mRNA expression of STAT4 indicates worse disease free-survival in gastric adenocarcinoma Batsaikhan Bat-Erdene (Mongolian National University of Medical Science, Mongolia)
3) A suggestion of modification of TNM staging for stage II/III gastric cancer based on prognostic single patient classifier algorithm Won Jun Seo (Yonsei University College of Medicine)
4) Prognostic roles of perioperative body mass index and weight loss in the long-term survival of gastric cancer patients Young Suk Park (Seoul National University Bundang Hospital)
5) Gastric cancer study: Mortality and morbidity in a tertiary cancer hospital in LMIC Nepal Kapendra Shekhar Amatya (Nepal Cancer Hospital & Research Centre, Nepal)
6) Magnetite core-shell nanoparticle mediated delivery of LCS-1 for synthetic lethal targeted therapy of BLM-defective hct116 colorectal cancer cells Anas Ahmad (Institute of Nano Science and Technology (INST), India)

Session Title	Basic research 4
Date & Time	6/22(Fri) 15:40-17:00	Place	Pine Room (3F)
1) Down-regulation of MicroRNA-17-5p promotes EMT by increasing vimentin in colorectal cancer Tae Won Kim (Samsung Medical Center, Sungkyunkwan University)
2) Metastasis-associated tumor antigen-1 (MTA-1): A plausible biomarker for tobacco-related oral squamous cell carcinoma and suitable targets for screening high-risk population Sadhna Aggarwal (All India Institute of Medical Sciences, India)
3) Discovery of bortezomib as a metastasis inhibitor to target GALNT14-TGF¥â metastatic pathway by Connectivity MAP based drug repositioning Ok-Seon Kwon (Seoul National Univeristy)
4) In-house LAMP and nPCR for detection of HPV 16 in oral cancer patients: comparision of isothermal and thermal technique Nurul Izzati Hamzan (Universiti Sains Malaysia, Malaysia)
5) MAPKAPK5 inhibition suppresses YAP-driven tumorigenesis Min Hwan Kim (Yonsei University College of Medicine)

Session Title	Head and neck cancer
Date & Time	6/22(Fri) 15:40-16:40	Place	Sapphire Ballroom A (3F)
1) Betel quid habits and risk of precancerous oral lesions among Paniya tribes of Wayanad, India- a cross-sectional study Shanavas Palliyal (DM Wayanad Institute of Medical Sciences, India)
2) Changes in the survival rates for and curability of HPV-related and non-HPV-related head and neck squamous cell carcinomas over 40 years: a population-based analysis using the SEER program Yi-Jun Kim (Seoul National University Hospital)
3) Immunoexpression of deltaNp63 in oral squamous cell carcinoma and its relationship to histological grades of malignancy Shakil Moidin (Al Rass Dental College, Saudi Arabia)
4) Detection of oral human papillomavirus in smoker and non-smoker subjects Fatin Hazwani Fauzi (Universiti Sains Malaysia, Malaysia)

Session Title	Genitourinary cancer
Date & Time	6/22(Fri) 15:40-16:10	Place	Sapphire Ballroom C (3F)
1) Mini laparatomy retropubic radical cystoprostatectomy in elderly: Its feasibility Robin Joshi (Kathmandu Medical College and Nepal Cancer Hospital, Nepal)
2) Combined blockade of PI3K/AKT and AR pathway with Phloretin as combination therapy in pre-clinical and patient derived xenografts of enzalutamide-resistant prostate cancer Sarita Saraswati (King Saud University, Saudi Arabia)

Session Title	H&N and other cancers
Date & Time	6/22(Fri) 09:00-10:00	Place	Sapphire Ballroom A (3F)
1) The prognostic value of albumin-to-alkaline phosphatase ratio before radical radiotherapy in patients with non-metastatic nasopharyngeal carcinoma Jae Sik Kim (Seoul National University College of Medicine)
2) Targeted deep sequencing of gastric marginal zone lymphoma identified alterations of TRAF3 and TNFAIP3 that were mutually exclusive for MALT1 rearrangement Jiyeon Hyeon (Incheon St. Mary's Hospital, the Catholic University of Korea College of Medicine)
3) Hepatic safety and biomarker assessments in sorafenib-experienced patients with advanced hepatocellular carcinoma treated with nivolumab in the CheckMate-040 study Yoon-Koo Kang (University of Ulsan College of Medicine)
4) Distinct immunological properties of the two histological subtypes of adenocarcinoma of the ampulla of vater Min Hwan Kim (Yonsei University College of Medicine)
5) A 4-gene signature for prediction of gastric cancer prognosis based on SVM Yoon Ho Ko (Uijeongbu St. Mary's Hospital, the Catholic University of Korea College of Medicine)

Session Title	Colorectal cancer
Date & Time	6/22(Fri) 09:00-10:00	Place	Sapphire Ballroom B (3F)
1) Pilot study of neoadjuvant chemotherapy with three cycles of capecitabine and oxaliplatin (CAPOX) for treatment of locally advanced colon cancer Soo Yeun Park (Kyungpook National University School of Medicine)
2) Impact of lymph node metastasis on oncologic outcomes of ypT0-2 rectal cancer treated with preoperative chemoradiotherapy: Not ignorable Eunhae Cho (University of Ulsan College of Medicine and Asan Medical Center)
3) Neoadjuvant rectal score as a potential surrogate marker for the prognosis of rectal cancer: a study from two institutions Chang Woo Kim (Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine)
4) Identification of novel biomarker for predicting pathologic complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer In Hee Lee (Kyungpook National University Chilgok Hospital)
5) Cancer chemotherapy activates type I IFN signaling through STAT1/2-mediated high order chromatin structure Jiwon Nam (Seoul National University College of Medicine)

Session Title	Breast and gynecologic cancer
Date & Time	6/22(Fri) 14:10-15:20	Place	Crystal Ballroom B (2F)
1) Prognostic impact of pre-treatment lymphocytopenia in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy Yong Jae Lee (Yonsei University College of Medicine)
2) LYL1 gene amplification predicts poor survival of patients with uterine corpus endometrial carcinoma: analysis of The Cancer Genome Atlas data Se Ik Kim (Seoul National University College of Medicine)
3) Research for the correlation between the expression of HER2/HER3 and the clinical feature of ovarian cancer Seongmin Kim (Korea University College of Medicine)
4) MicroRNA-137 inhibits cancer progression by targeting DEL-1 in triple negative breast cancer cells, MDA-MB-231 Soo Jung Lee (Kyungpook National University Hospital)
5) XAF1 directs apoptotic switch of estrogen function by promoting BRCA1-mediated ERa ubiquitination and degradation Ji-Sun Lim (Korea University)
6) A therapeutic perspective on anti-EGFR targeting hormone receptor positive breast cancer Yisun Jeong (Sungkyunkwan University)
7) Efficacy and safety of peritoneal mesometrial resection for endometrial cancer: a prospective cohort study with historical comparison Nara Lee (Seoul National University College of Medicine)

Session Title	Genitourinary Cancer
Date & Time	6/22(Fri) 16:10-16:40	Place	Sapphire Ballroom C (3F)
1) Antitumor effects of recombinant mycobacterium bovis bacillus Calmette-Guérin (rBCG) on bladder cancer cells Min Ji Cho (Chung-Ang University College of Medicine)
2) Psychiatric comorbidities among prostate cancer survivors in South Korea: A nationwide population-based, longitudinal study Jaesung Heo (Ajou University School of Medicine)

Date & Time	6/22(Fri) 09:00-17:00	Place	Emerald Room (2F)